Asia Pacific Herald
SEE OTHER BRANDS

The latest news from Asia and the Pacific

Asia Pacific Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.

Press releases published on March 31, 2025

OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod

OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod

Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term Stability Urcosimod stable in single-use ampoules for more than 2½ years FDA requires drug to show long-term shelf stability for approval Daily administration to …

Cell to Pack Battery Market Innovations, Trends, and Growth Outlook | Exactitude Consultancy

Cell to Pack Battery Market Innovations, Trends, and Growth Outlook | Exactitude Consultancy

Luton, Bedfordshire, United Kingdom, March 31, 2025 (GLOBE NEWSWIRE) -- The global Cell to Pack (CTP) Battery Market is set to reach a valuation of approximately $18 billion in 2024, driven by surging demand for electric vehicles (EVs) and renewable energy …

Revival Gold Delivers Compelling PEA Results and Attractive Potential Re-development Timeline for the Mercur Gold Project

Revival Gold Delivers Compelling PEA Results and Attractive Potential Re-development Timeline for the Mercur Gold Project

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce compelling results from a Preliminary Economic Assessment (“PEA”) on the Company’s Mercur Gold Project (“Mercur …

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in H2 2025 Raised $140 Million in Gross Proceeds in Upsized IPO in …

Gold Nanoparticles Market worth $1.11 billion in 2029, at a 16.3%, says MarketsandMarkets™

Gold Nanoparticles Market worth $1.11 billion in 2029, at a 16.3%, says MarketsandMarkets™

Delray Beach, FL, March 31, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Gold Nanoparticles Market  size is expected to reach USD 1.11 billion in 2029 from USD 0.50 billion in 2024, at a CAGR of 16.3%, as per the recent study by MarketsandMarkets™. The …

Diginex Limited and Forvis Mazars Announce Strategic Alliance to Enhance Supply Chain Risk Assessment with diginexLUMEN

Diginex Limited and Forvis Mazars Announce Strategic Alliance to Enhance Supply Chain Risk Assessment with diginexLUMEN

LONDON, March 31, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex Limited” or the “Company”) (NASDAQ: DGNX), a leading impact technology company focused on solving pressing environmental, social, and governance (ESG) challenges, today announced a …

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

MINNEAPOLIS and BRISBANE, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting- …

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high …

Ocular Therapeutix™ to Participate in Two Investor Conferences in April

Ocular Therapeutix™ to Participate in Two Investor Conferences in April

BEDFORD, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that the Company will participate in two investor conferences …

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

– FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track – – Enrolling approximately one patient per week across the RESET™ clinical development program since ACR Convergence presentation in November 2024 with 33 …

Kaspi.kz: Announcement of AGM Results

Kaspi.kz: Announcement of AGM Results

ALMATY, Kazakhstan, March 31, 2025 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (Nasdaq: KSPI) announces that the following resolutions were duly passed at its Annual General Meeting on 28 March 2025: To approve the agenda of the Annual General Meeting …

Azimut to Initiate a Scoping Study on the Patwon Gold Zone at its Flagship Elmer Project

Azimut to Initiate a Scoping Study on the Patwon Gold Zone at its Flagship Elmer Project

Prospecting Continues to Deliver Excellent Gold and Copper Results                                     Up to 181.5 g/t Au, 345 g/t Ag, 301 g/t Te (Gabbro Zone)                                     Up to 9.62 g/t Au, 8.43 g/t Ag, 13.4 g/t Te (Gabbro East) …

Azimut lance une étude d’orientation pour la Zone aurifère Patwon  sur son projet-phare Elmer

Azimut lance une étude d’orientation pour la Zone aurifère Patwon sur son projet-phare Elmer

La prospection continue de livrer d’excellents résultats en or et en cuivre Jusqu’à 181,5 g/t Au, 345 g/t Ag, 301 g/t Te (Zone Gabbro) Jusqu’à 9,62 g/t Au, 8,43 g/t Ag, 13,4 g/t Te (Gabbro Est) Jusqu’à 5,09 g/t Au, 172 g/t Ag, 7,53 % Cu, 670 g/t Bi (Wolf …

First Atlantic Nickel Announces $1M Premium No Warrant Charity Flow Through Private Placement

First Atlantic Nickel Announces $1M Premium No Warrant Charity Flow Through Private Placement

VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or the “Company”) announces that it intends to complete a non-brokered private placement financing of up to …

Smart Powerr Corp. Reached a Strategic Cooperation  to Build an Integrated Industrial Ecology of Optical Storage, Charging and Inspection

Smart Powerr Corp. Reached a Strategic Cooperation to Build an Integrated Industrial Ecology of Optical Storage, Charging and Inspection

XI’AN, China, March 31, 2025 (GLOBE NEWSWIRE) -- Smart Powerr Corp. (NASDAQ: CREG) (“CREG” or the “Company”), an industrial waste-to-energy solution provider in China, announced today that it and Shidai Huazhi (Jiangsu) Energy Technology Co., Ltd. …

Nova Minerals Provides an Invitation to Investor Webinars

Nova Minerals Provides an Invitation to Investor Webinars

Melbourne, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) is pleased to provide an opportunity for its shareholders, investors, and the broader market to attend live …

IREN Business Update

IREN Business Update

Bitcoin Mining Expansion Paused at 52 EH/s Progressing Debt Financing Workstreams SYDNEY, March 31, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN”), today provided a business update and strategic outlook, …

Ero Copper Extends Precious Metals Purchase Arrangements with Royal Gold by US$50 million at the Xavantina Operations

Ero Copper Extends Precious Metals Purchase Arrangements with Royal Gold by US$50 million at the Xavantina Operations

(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) is pleased to announce that, in return for upfront proceeds of $50 million, …

Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in Healthy Volunteers

Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in Healthy Volunteers

Trial achieved key objectives for safety, tolerability, pharmacokinetics and pharmacodynamics Clinical data from this trial, together with preclinical data, support the therapeutic potential of KER-065 for broad impact in Duchenne muscular dystrophy (“DMD …

Global Engine Group Holding Limited Announces Extraordinary General Meeting Results and Approval of Dual-Class Share Structure

Global Engine Group Holding Limited Announces Extraordinary General Meeting Results and Approval of Dual-Class Share Structure

HONG KONG, March 31, 2025 (GLOBE NEWSWIRE) -- Global Engine Group Holding Limited (Nasdaq: GLE) (the “Company” or “GLE”), a Hong Kong-headquartered integrated solutions provider in information communication technologies, today announced the results of the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service